Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Asset Resilience Ratio

Latest as of March 2026: 0.00%

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited asset resilience ratio. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has an Asset Resilience Ratio of 0.00% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Guangzhou Baiyunshan Pharmaceutical Hold defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€4.00 Million

≈ $4.68 Million USD Cash + Short-term Investments

Total Assets

€89.76 Billion

≈ $104.94 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2015–2025)

Asset resilience ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2015 to 2025. This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's Asset Resilience Ratio has changed over time. Read GU5 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Guangzhou Baiyunshan Pharmaceutical Hold (GU5) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€4.00 Million	0.0%
Total Liquid Assets	€4.00 Million	0.00%

Asset Resilience Insights

Limited Liquidity: Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Industry Peers by Asset Resilience Ratio

Compare Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hanmi Science KO:008930	Medical Distribution	0.04%
Guangxi Liuzhou Pharm Co Ltd SHG:603368	Medical Distribution	1.77%
ShareHope Medicine Co Ltd TWO:8403	Medical Distribution	3.61%
Sigma Healthcare Ltd AU:SIG	Medical Distribution	0.03%
Ebos Group Ltd AU:EBO	Medical Distribution	0.00%
Paragon Care Ltd AU:PGC	Medical Distribution	0.00%
Mayne Pharma Group Ltd AU:MYX	Medical Distribution	4.00%
Profarma Distribuidora de Produtos Farmacêuticos S.A SA:PFRM3	Medical Distribution	4.48%

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Asset Resilience Ratio by Year (2015–2025)

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.00%	€4.00 Million ≈ $4.68 Million	€84.51 Billion ≈ $98.80 Billion	0.00pp
2023-12-31	0.01%	€4.00 Million ≈ $4.68 Million	€78.59 Billion ≈ $91.88 Billion	-0.07pp
2022-12-31	0.08%	€56.87 Million ≈ $66.49 Million	€74.67 Billion ≈ $87.29 Billion	+0.07pp
2020-12-31	0.01%	€4.00 Million ≈ $4.68 Million	€59.76 Billion ≈ $69.87 Billion	-2.99pp
2018-12-31	3.00%	€1.54 Billion ≈ $1.80 Billion	€51.48 Billion ≈ $60.19 Billion	+2.98pp
2017-12-31	0.02%	€4.88 Million ≈ $5.70 Million	€28.31 Billion ≈ $33.10 Billion	-0.01pp
2016-12-31	0.02%	€6.03 Million ≈ $7.05 Million	€25.90 Billion ≈ $30.28 Billion	-0.25pp
2015-12-31	0.27%	€43.19 Million ≈ $50.49 Million	€15.87 Billion ≈ $18.55 Billion	--

pp = percentage points

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

F:GU5 Germany Medical Distribution

Market Cap

$372.78 Million

€318.86 Million EUR

Market Cap Rank

#13474 Global

#1409 in Germany

Share Price

€1.45

Change (1 day)

+2.11%

52-Week Range

€1.41 - €2.30

All Time High

€2.30